TLX — Telix Pharmaceuticals Limited stock price, charts and financials

QT53Telix Pharmaceuticals Limited

Telix Pharmaceuticals Limited (NASDAQ: TLX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
11.79
+0.27+2.34%
OverviewShort InterestFilings
TLXQT53Telix Pharmaceuticals Limited·NASDAQ
11.79+2.34%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 21, 20266-KForeign issuer report
Jul 02, 20266-KForeign issuer report
May 21, 20266-KForeign issuer report
May 18, 20263Initial statement of beneficial ownership
May 18, 20263Initial statement of beneficial ownership
May 18, 20263Initial statement of beneficial ownership
May 06, 20264Statement of changes in beneficial ownership
Apr 23, 20266-KForeign issuer report
Apr 21, 20266-KForeign issuer report
Apr 20, 20266-KForeign issuer report
Apr 14, 20266-KForeign issuer report
Apr 14, 20266-KForeign issuer report
Apr 13, 20266-KForeign issuer report
Apr 10, 20266-KForeign issuer report
Apr 09, 20266-KForeign issuer report
Apr 07, 20266-KForeign issuer report
Apr 02, 20266-KForeign issuer report
Apr 01, 20263Initial statement of beneficial ownership
Apr 01, 20263Initial statement of beneficial ownership
Apr 01, 20263Initial statement of beneficial ownership
Apr 01, 20264Statement of changes in beneficial ownership
Apr 01, 20263Initial statement of beneficial ownership
Mar 20, 202620-F/A20-F/A
Mar 18, 20263Initial statement of beneficial ownership
Mar 18, 20263Initial statement of beneficial ownership
#1 / 25 of 97
Page
▼
/ 4